American Heart Journal
Volume 151, Issue 5 , Pages 956-961 , May 2006

The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial

Received 10 November 2005 ,Accepted 5 February 2006.

References 

  1. American Heart Association . 2004 Heart and Stroke Statistical Update, American Heart Association. Available at http://www.americanheart.or/presenter.jhtmlAccessed September 2005
  2. American Heart Association . Heart and Stroke Statistical Update. 2001;
  3. Blackehear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–759
  4. Peterson P, et al. Placebo-controlled, Randomized Trial of Warfarin and Aspirin for Prevention of Thromboembolic Complications in Chronic Atrial Fibrillation; The Copenhagen AFASAK Study. Lancet. 1989;8631:175–179
  5. Stroke Prevention in Atrial Fibrillation Study . Final Results. Circulation. 1991;84:527–539
  6. Warfarin versus Aspirin for Prevention of Thromboembolism in Atrial Fibrillation . Stroke Prevention in Atrial Fibrillation II Study. Lancet. 1994;343:987–991
  7. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with Atrial Fibrillation III Randomized Clinical Trial. Lancet. 1996;348:633–638
  8. Gottlieb LK, Salem-Schatz S. Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?. Arch Intern Med. 1994;154:1945–1953
  9. Hart R, Boop B, et al. Oral anticoagulants and intracranial hemorrhage. Stroke. 1995;26:1471–1477
  10. Sportif Executive Steering Committee for the SPORTIF V Investigators* . Ximelagatran vs Warfarin for stroke prevention in patients with non-valvular atrial fibrillation: A Randomized Trial. JAMA. 2005;293:690–698
  11. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke. Results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864–2870
  12. Gelman A, Carlin JB, Stern HS, et al. In: Bayesian Data Analysis. Boca Raton: CRC Press; 2003;p. 668
  13. Ernst G, Stollberger C, Abzierher F, et al. Morphology of the left atrial appendage. Anat Rec. 1995;242:553–561
  14. Cox J, Ad N, Palazzo T. Impact of the Maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg. 1999;118:840–883
  15. Sherman D, Kim S, et al. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of sinus rhythm Management (AFFIRM) study. Arch Intern Med. 2005;165:1185–1191
  16. Crystal E, Lamy A, Connolly S, et al. Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention. Am Heart J. 2003;145:174–178
  17. Blackshear J, Johnson D, Odell J, et al. Thorascopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol. 2003;42:1249–1252
  18. Ostermayer S, Reisman M, Kramer P, et al. Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO System) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation. J Am Coll Cardiol. 2005;46:9–14

PII: S0002-8703(06)00125-6

doi: 10.1016/j.ahj.2006.02.005

American Heart Journal
Volume 151, Issue 5 , Pages 956-961 , May 2006

Article Tools

* Image Usage & Resolution